Both in Pharmaceuticals
Enliven Therapeutics vs Parabilis Medicines
Over the past year ELVN returned −13.0% and PBLS returned −17.7%; their daily moves had a correlation of 0.52.
ELVN −13.0% PBLS −17.7%Growth of $1, one year, split-adjusted
| Metric | ELVN | PBLS |
|---|---|---|
| Price | $47.25 | $30.36 |
| Market cap | $3.46B | $3.75B |
| Today | +5.40% | +3.79% |
| 1 month | +11.5% | +5.2% |
| 6 months | +14.7% | — |
| Year to date | +206.8% | — |
| 1 year | +136.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −45239.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $895.2M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | — |
| Short % of float | 16.4% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).